# Pharmacology

## Cytochrome P-450 (CYP450) Interactions

### Inducers {CSGAR-PP}

- Carbamazepine
- St. John wort
- Griseofulvin
- Alcohol :: chronic
- Rifampin
- Phenytoin
- Phenobarbital

### Substrates {ATWO}

- Anticonvulsants
- Acetaminophen
- Theophylline
- Warfarin
- OCP

### Inhibitors {CIGAR-MASK-QQ}

- Cimetidine
- Isoniazid
- Grapefruit
- Alcohol :: acute
- Ritonavir
- Macrolide
- Amiodarone
- Sulfonamide
- Ketoconazole
- Quinolone
- Quinidine

## Sulfa Drugs {P-FACTSSS}

- Probenecid
- Furosemide
- Acetazolamide
- Celecoxib
- Thiazide
- Sulfonamide
- Sulfasalazine
- Sulfonylurea

## Mechanisms of Action of Medications Targeting Ion Channels

|Mechanism|Medication|Indications|
|-|-|-|
|Na channel activators|Batrachotoxin & Ciguatoxin|-|
|Na channel blockers|Class 1 antiarrhythmics|Arrhythmia|
||Caines|Anesthesia|
||Amiloride & Triamterene|Diuretics :: K-sparing diuretics|
||Carbamazepine|Seizure & Bipolar|
||Phenytoin|Seizure|
||Calcium|-|
||Saxitoxin & Tetrodotoxin|-|
|K channel activators|Diazoxide|Vasodilation & Insulinoma|
||Minoxidil|Vasodilation & Alopecia|
|K channel blockers|Class 3 antiarrhythmics|Arrhythmia|
||Sulfonylurea|DM type 2|
||Aminopyridine|-|
|Ca channel activators|-|-|
|Ca channel blockers|Class 4 antiarrhythmics|Arrhythmia|
||-Dipines|Vasodilation|
||Dantrolene|Malignant hyperthermia & Neuroleptic malignant syndrome|
||Ethosuximide|Seizure :: absence|
||Gabapentin|Seizure & Neuropathic pain|
||Pregabalin|Seizure & Neuropathic pain|
|Na-K pump blockers|Digoxin & Digitalis|Arrhythmia & Inotrope|
||Ouabain|-|
|H-K pump blockers|Proton pump inhibitors (PPI) [-Prazoles]|PUD|
|Na-Cl sympoter blockers|Thiazide|Diuretics|
|Na-K-2Cl sympoter blockers|Loop diuretics:<br>Furosemide<br>Bumetanide<br>Torsemide|Diuretics|
|Na-I sympoter blockers|Thiocyanate<br>Perchlorate<br>Iodine|Hyperthyroidism|

## Mechanisms of Action of Medications Targeting Cholinergic Neurons

|Mechanism|Medication|Indications|
|-|-|-|
|Choline uptake inhibitors|Hemicholinium|-|
|Vesicular transporter inhibitors|Vesamicol|-|
|ACh release inhibitors|Botulinum toxin|Muscle relaxant|
|ACh release inducers|-|-|

## Mechanisms of Action of Medications Targeting Adrenergic Neurons

|Mechanism|Medication|Indications|
|-|-|-|
|Tyrosine uptake inhibitors|-|-|
|Vesicular transporter inhibitors|Reserpine|Huntington|
||Tetrabenazine|Huntington|
|NE release inhibitors|Bretylium|Arrhythmia|
||Guanethidine|HTN|
|NE release inducers|Tyramine|-|
||Ephedrine|Decongestant|
||Amphetamine|ADHD & Narcolepsy|
||Modafinil|ADHD & Narcolepsy|

## Mechanisms of Action of Medications Targeting Neurotransmitter Release

|Mechanism|Medication|Indications|
|-|-|-|
|ACh release inhibitors|Botulinum toxin|Muscle relaxant|
|ACh release inducers|-|-|
|NE release inhibitors|Bretylium|Arrhythmia|
||Guanethidine|HTN|
|NE release inducers|Tyramine|-|
||Ephedrine|Decongestant|
||Amphetamine|ADHD & Narcolepsy|
||Modafinil|ADHD & Narcolepsy|
|GABA & Glycine release inhibitors|Tetanus toxin|-|
|GABA & Glycine release inducers|-|-|

## Mechanisms of Action of Medications Targeting Neurotransmitter Breakdown

|Mechanism|Medication|Indications|
|-|-|-|
|ACh esterase inhibitors|Edrophonium|Myasthenia diagnosis|
||Pyridostigmine|Myasthenia|
||Neostigmine|Muscle relaxant reversal|
||Physostigmine|Atropine antidote|
||Rivastigmine|Alzheimer|
||Galantamine|Alzheimer|
||Donepezil|Alzheimer|
||Organophosphate & Sarin|Glaucoma|
|MAO inhibitors|Tranylcypromine|Depression|
||Phenelzine|Depression|
||Isocarboxazid|Depression|
||Selegiline|Depression & Parkinson|

## Mechanisms of Action of Medications Targeting Neurotransmitter Reuptake

|Mechanism|Medication|Indications|
|-|-|-|
|NE reuptake inhibitors|Cocaine|Anesthesia|
||Atomoxetine|ADHD|
||Amphetamine|ADHD & Narcolepsy|
||Methylphenidate|ADHD & Narcolepsy|
||TCA & SNRI & NDRI|Depression|
|5-HT reuptake inhibitors|TCA & SNRI & SSRI|Depression|

## Mechanisms of Action of Cholinergic Agonists

|Mechanism|Medication|Indications|
|-|-|-|
|M agonists|Bethanechol|Urinary retention|
||Methacholine|Asthma diagnosis|
||Carbachol|Glaucoma|
||Pilocarpine|Glaucoma & Xerophthalmia & Xerostomia|
|N<sub>N</sub> [Ganglionic] agonists|Nicotine|Stimulant|
|N<sub>M</sub> [Neuromuscular] agonists|Succinylcholine|Muscle relaxant|

## Mechanisms of Action of Cholinergic Antagonists

|Mechanism|Medication|Indications|
|-|-|-|
|M antagonists|Atropine & Tropicamide|Mydriatics & Cycloplegia|
||Benztropine|Parkinson|
||Ipratropium & Tiotropium|Asthma|
||Scopolamine|Emesis :: motion sickness|
||Oxybutynin & Tolterodine|Urinary incontinence|
||Glycopyrrolate|Anesthesia|
||Antipsychotics|-|
||Antidepressants :: TCA|-|
||1° Antihistamines|-|
|N<sub>N</sub> [Ganglionic] antagonists|Hexamethonium|-|
||Mecamylamine|-|
|N<sub>M</sub> [Neuromuscular] antagonists|Atracurium|Muscle relaxant|
||Rocuronium|Muscle relaxant|

## Mechanisms of Action of Adrenergic Agonists

|Mechanism|Medication|Indications|
|-|-|-|
|α<sub>1</sub> agonists|Norepinephrine: α<sub>1</sub> > β<sub>1</sub>|Hypotension|
||Phenylephrine|Hypotension & Decongestant|
||Midodrine|Hypotension|
|α<sub>2</sub> agonists|Clonidine|HTN & Opioid withdrawal|
||Brimonidine|Glaucoma|
||Methyldopa|HTN|
|β<sub>1</sub> agonists|Dopamine: D > β<sub>1</sub> > α<sub>1</sub>|Inotrope|
||Dobutamine: β<sub>1</sub> > β<sub>2</sub>|Inotrope|
|β<sub>2</sub> agonists|Albuterol|Asthma :: acute|
||Salmeterol & Formoterol|Asthma :: chronic|
||Terbutaline & Ritodrine|Tocolysis|
|β agonists|Epinephrine: β > α<sub>1</sub>|Hypotension & Asthma & Shock|
||Isoproterenol: β|-|

## Mechanisms of Action of Adrenergic Antagonists

|Mechanism|Medication|Indications|
|-|-|-|
|α<sub>1</sub> antagonists|Tamsulosin|BPH|
||Terazosin|BPH & HTN & PCC|
||Doxazosin|BPH & HTN & PCC|
||Prazosin|BPH & HTN & PCC & PTSD|
|α<sub>2</sub> antagonists|Mirtazapine|Depression|
|α antagonists|Phentolamine|PCC|
||Phenoxybenzamine|PCC|
||Antipsychotics|-|
||Antidepressants :: TCA|-|
||1° Antihistamines|-|
|β<sub>1</sub> antagonists|Acebutolol|Partial agonists|
||Atenolol|Arrhythmia|
||Bisoprolol|HF|
||Esmolol|Arrhythmia & Surgery|
||Metoprolol|Arrhythmia & HF|
|β antagonists|Nadolol|-|
||Pindolol|Partial agonists|
||Propranolol|Arrhythmia|
||Sotalol|Arrhythmia|
||Timolol|Arrhythmia & Glaucoma|
|αβ antagonists|Carvedilol|Arrhythmia & HF|
||Labetalol|Hypertension|

## Cholinergic & Adrenergic Effects {DUMBBEELSS}

|Cholingeric|Adrenergic|
|-|-|
|Diarrhea|Constipation|
|Urinary incontinence|Urinary retention|
|Miosis|Mydriasis & Cycloplegia|
|Bronchoconstriction|Bronchodilation|
|Bradycardia|Tachycardia|
|Emesis|-|
|Excitation|-|
|Lacrimation|Xerophthalmia|
|Salivation|Xerostomia|
|Sweating|Sweating|

## Mechanisms of Action of Medications Targeting Dopamine Receptor

|Mechanism|Medication|Indications|
|-|-|-|
|D<sub>2</sub> agonists|Bromocriptine|Parkinson & Prolactinoma|
||Cabergoline|Parkinson & Prolactinoma|
||Pramipexole|Parkinson|
||Ropinirole|Parkinson|
|D<sub>2</sub> antagonists|Metoclopramide<br>Prochlorperazine<br>Domperidone<br>Droperidol|Emesis|
||Antipsychotics|Psychosis|

## Mechanisms of Action of Medications Targeting Serotonin Receptor

|Mechanism|Medication|Indications|
|-|-|-|
|5-HT<sub>1</sub> agonists|Buspirone|Anxiety|
||-Triptans|Migraine|
||Ergotamine|Migraine|
|5-HT<sub>2</sub> antagonists|2° Antipsychotics|Psychosis & Bipolar|
||Cyproheptadine|Carcinoid & Serotonin syndrome|
|5-HT<sub>3</sub> antagonists|-Setrons|Emesis|
|5-HT<sub>4</sub> agonists|Cisapride|Constipation|
|5-HT modulators|Trazodone|Depression & Insomnia|

## Mechanisms of Action of Medications Targeting Histamine Receptor

|Mechanism|Medication|Indications|
|-|-|-|
|H<sub>1</sub> antagonists :: 1°|Chlorpheniramine<br>Diphenhydramine<br>Meclizine<br>Promethazine|Allergy<br>Emesis :: motion sickness|
|H<sub>1</sub> antagonists :: 2°|Cetirizine<br>Fexofenadine<br>Loratadine|Allergy|
|H<sub>1</sub> antagonists|Antipsychotics|-|
||Antidepressants :: TCA|-|
|H<sub>2</sub> antagonists|Cimetidine<br>Ranitidine<br>Famotidine<br>Nizatidine|PUD|

## Mechanisms of Action of Medications Targeting Glutamate Receptor

|Mechanism|Medication|Indications|
|-|-|-|
|NMDA agonists|-|-|
|NMDA antagonists|Ketamine|Anesthesia|
||Memantine|Alzheimer|
||Amantadine|Parkinson|
||Riluzole|Amyotrophic lateral sclerosis (ALS)|
||Dextromethorphan|Coughing|

## Mechanisms of Action of Medications Targeting GABA Receptor

|Mechanism|Medication|Indications|
|-|-|-|
|GABA-A agonists|Barbiturate|Anesthesia & Seizure|
||Benzodiazepine|Anesthesia & Seizure|
||Propofol|Anesthesia|
||Etomidate|Anesthesia|
||Alcohol|-|
|GABA-B agonists|Baclofen|Spasm|
|GABA-A antagonists|Flumazenil|Benzodiazepine antidote|
|GABA-B antagonists|-|-|

## Mechanisms of Action of Medications Targeting Opioid Receptor

|Mechanism|Medication|Indications|
|-|-|-|
|μ-opioid agonists|Codeine|Analgesia|
||Tramadol|Analgesia|
||Meperidine|Analgesia|
||Morphine|Analgesia & Venodilators|
||Fentanyl|Analgesia|
||Loperamide|Diarrhea|
||Diphenoxylate|Diarrhea|
||Dextromethorphan|Coughing|
||Methadone|Opioid cessation|
||Buprenorphine|Opioid cessation|
||Heroin|-|
|μ-opioid antagonists|Naloxone|Opioid antidote|
||Naltrexone|Alcohol cessation|

## Mechanisms of Action of Medications Targeting Growth Hormone

|Mechanism|Medication|Indications|
|-|-|-|
|Somatostatin agonists|Octreotide|Acromegaly|
||Lanreotide|Acromegaly|
|GH antagonists|Pegvisomant|Acromegaly|
|IGF-1 agonists|Mecasermin|Dwarfism|

## Mechanisms of Action of Medications Targeting Thyroid Hormone

|Mechanism|Medication|Indications|
|-|-|-|
|Thyroid peroxidase inhibitors|Propylthiouracil|Hyperthyroidism|
||Methimazole|Hyperthyroidism|
||Iodine [Lugol] solution|Hyperthyroidism|
|Deiodinase inhibitors|Propylthiouracil|Hyperthyroidism|
||Propranolol & Steroids|Hyperthyroidism|
|TH agonists|Levothyroxine|Hypothyroidism|
||Triiodothyronine|Hypothyroidism|

## Mechanisms of Action of Medications Targeting Sex Hormones

|Mechanism|Medication|Indications|
|-|-|-|
|GnRH agonists|Leuprolide :: pulsatile|Infertility|
|GnRH antagonists|Leuprolide :: continuous|Prostate cancer|
||Cetrorelix & Ganirelix|Infertility|
|LH agonists|Lutropin & Menotropin|Infertility|
|FSH agonists|Follitropin & Menotropin|Infertility|
|hCG agonists|Choriogonadotropin|Infertility|
|Estrogen agonists|Diethylstilbestrol (DES)|HRT & OCP|
||Mestranol|HRT & OCP|
|Estrogen modulators|Clomifene|PCOS & Ovulation|
||Tamoxifen|Breast cancer|
||Raloxifene|Breast cancer & Osteoporosis|
|Progesterone agonists|Progestin|HRT & OCP|
||Medroxyprogesterone|HRT & OCP|
||Norethindrone|HRT & OCP|
||Desogestrel|HRT & OCP|
|Progesterone antagonists|Mifepristone [RU486]|Abortion|
|Aromatase inhibitors|Anastrozole|Breast cancer|
||Letrozole|Breast cancer|
||Exemestane|Breast cancer|
|Androgen agonists|Danazol|Hypogonadism & Endometriosis|
||Methyltestosterone|Hypogonadism|
|Androgen antagonists|Flutamide|Prostate cancer|
||Bicalutamide|Prostate cancer|
||Ketoconazole|PCOS|
||Spironolactone|PCOS|
|5α-Reductase inhibitors|Finasteride|BPH & Alopecia|
||Spironolactone|Hirsutism|

## Mechanisms of Action of Medications Targeting Vasopressin Receptor

|Mechanism|Medication|Indications|
|-|-|-|
|V<sub>2</sub> agonists|Desmopressin|DI|
|V<sub>2</sub> antagonists|-Vaptans|SIADH|

## Mechanisms of Action of Medications Targeting Oxytocin Receptor

|Mechanism|Medication|Indications|
|-|-|-|
|Oxytocin agonists|Carbetocin|Labor|
|Oxytocin antagonists|Atosiban|Tocolysis|

## Mechanisms of Action of Medications Targeting Autacoid Receptor

|Mechanism|Medication|Indications|
|-|-|-|
|PGE1 agonists|Misoprostol|Abortion & PUD|
||Alprostadil|Impotence & PDA maintenance|
|PGF2 agonists|Latanoprost|Glaucoma|
|PGI2 agonists|Epoprostenol|Pulmonary HTN|
|TXA2 antagonists|-|-|
|LTD<sub>4</sub> antagonists|Montelukast|Asthma|
||Zafirlukast|Asthma|

## Mechanisms of Action of Medications Targeting Enzymes

|Mechanism|Medication|Indications|
|-|-|-|
|PDE inhibitors|Inamrinone & Milrinone|Inotrope|
||Methylxanthine: Theophylline & Caffeine|Asthma|
||Sildenafil & Vardenafil|Impotence & Pulmonary HTN|
||Dipyridamole & Cilostazol|Antiplatelet & Vasodilation|
|COX inhibitors :: NSAIDs|Aspirin<br>Ibuprofen<br>Naproxen<br>Diclofenac<br>Ketorolac<br>Meloxicam<br>Indomethacin|Antipyresis<br>Analgesia<br>Inflammation<br>Tocolysis<br>PDA closure|
|COX inhibitors|Acetaminophen|Antipyresis<br>Analgesia|
||Sulfasalazine|Inflammation|
|COX-2 inhibitors|Celecoxib|Arthritis|
|LOX inhibitors|Zileuton|Asthma|
|ADH inhibitors|Ethanol|Methanol antidote|
||Fomepizole|Methanol antidote|
|ALDH inhibitors|Disulfiram|Alcohol cessation|
|Xanthine oxidase inhibitors|Allopurinol|Gout :: chronic|
||Febuxostat|Gout :: chronic|

## Mechanisms of Action of Antimicrobials and Antineoplastics

|Mechanism|Target|Species|
|-|-|-|
|Cell wall inhibitors|Peptidoglycan|Bacterium|
||Mycolate|Mycobacterium|
||Arabinogalactan|Mycobacterium|
||β-glucan|Fungus|
|Cell membrane inhibitors|Ergosterol|Fungus|
||Cholesterol|Human|
|Nucleotide inhibitors|Purine & Pyrimidine & Folate|-|
|DNA inhibitors|DNA|-|
|RNA inhibitors|RNA|-|
|Microtubule inhibitors|Microtubule|-|
|Protein inhibitors|Ribosome|-|

### Cell Wall Inhibitors

|Mechanism|Target|Medication|Species|
|-|-|-|-|
|↓ Peptidoglycan crosslinking|Penicillin binding protein|Penicillin|Bacterium|
|||Cephalosporin|Bacterium|
|||Monobactam|Bacterium|
|||Carbapenem|Bacterium|
|↓ Peptidoglycan synthesis|Peptidoglycan|Glycopeptide|Bacterium|
|↓ Mycolate synthesis|Enoyl-ACP reductase|Isoniazid|Mycobacterium|
|↓ Arabinogalactan synthesis|Arabinosyl transferase|Ethambutol|Mycobacterium|
|↓ β-glucan synthesis|Glucan synthase|Echinocandin|Fungus|

### Cell Membrane Inhibitors

|Mechanism|Target|Medication|Species|
|-|-|-|-|
|↑ Cell membrane damage|-|Daptomycin|Bacterium|
||-|Polymyxin|Bacterium|
||Ergosterol|Amphotericin B|Fungus|
|||Nystatin|Fungus|
|↓ Ergosterol synthesis|Squalene epoxidase|Terbinafine|Fungus|
||Demethylase|Azoles|Fungus|

### Nucleotide Inhibitors

|Mechanism|Target|Medication|Species|
|-|-|-|-|
|↓ Purine synthesis|IMP dehydrogenase|Ribavirin|Virus|
|||Mycophenolate|Human|
||PRPP amidotransferase|Azathioprine|Human|
|||6-Mercaptopurine (6-MP)|Human|
|||6-Thioguanine (6-TG)|Human|
|↓ Pyrimidine synthesis|Dihydroorotate dehydrogenase|Leflunomide|Human|
||Thymidylate synthase|Flucytosine|Fungus|
|||5-Fluorouracil (5-FU)|Human|
|↓ dNTP synthesis|Ribonucleotide reductase|Hydroxyurea|Human|
|↓ Folate synthesis|Dihydropteroate synthase|Sulfonamides:<br>Sulfamethoxazole<br>Sulfisoxazole<br>Sulfadiazine|Bacterium|
||Dihydrofolate reductase|Trimethoprim|Bacterium|
|||Pyrimethamine|Protozoa|
|||Methotrexate|Human|

### DNA Inhibitors

|Mechanism|Target|Medication|Species|
|-|-|-|-|
|↓ DNA synthesis|Reverse transcriptase|NRTI|Virus|
|||NNRTI|Virus|
||DNA polymerase|Acyclovir<br>Famciclovir<br>Ganciclovir<br>Cidofovir<br>Foscarnet|Virus|
|||Cladribine<br>Cytarabine<br>Gemcitabine|Human|
||Topoisomerase|Fluoroquinolone|Bacterium|
||Topoisomerase 1|Camptothecins [-Tecans]|Human|
||Topoisomerase 2|Podophyllotoxins [-Posides]|Human|
|↓ DNA methylation|DNA methyltransferase|Azacitidine|Human|
|||Decitabine|Human|
|↑ DNA intercalation|DNA|Metronidazole|Bacterium|
|||Streptomycin|Mycobacterium|
|||Anthracyclines [-Rubicins]|Human|
|||Bleomycin|Human|
|↑ DNA crosslinking|DNA|Busulfan|Human|
|||Cyclophosphamide|Human|
|||Nitrosourea|Human|
|||Platinums [-Platins]|Human|

### RNA Inhibitors

|Mechanism|Target|Medication|Species|
|-|-|-|-|
|↓ RNA synthesis|RNA polymerase|Rifampin|Mycobacterium|
|||Dactinomycin|Human|
|||α-Amanitin|Human|

### Microtubule Inhibitors

|Mechanism|Target|Medication|Species|
|-|-|-|-|
|↓ Microtubule assembly|Microtubule|Benzimidazole|Parasite|
|||Griseofulvin|Fungus|
|||Colchicine|Human|
|||Vinca alkaloids|Human|
|↓ Microtubule disassembly|Microtubule|Taxanes [-Taxels]|Human|

### Protein Inhibitors

|Mechanism|Target|Medication|Species|
|-|-|-|-|
|↓ Protein synthesis|-|IFN-α|Virus|
||30S ribosome :: initiation complex|Aminoglycoside|Bacterium|
||50S ribosome :: initiation complex|Linezolid|Bacterium|
||30S ribosome :: tRNA binding|Tetracycline|Bacterium|
||50S ribosome :: peptidyl transferase|Chloramphenicol|Bacterium|
||50S ribosome :: mRNA translocation|Macrolide|Bacterium|
|||Clindamycin|Bacterium|
||Elongation factor (EF-2)|Diphtheria toxin|Human|
|||Exotoxin A|Human|
||60S ribosome|Shiga toxin|Human|
|||Shiga-like toxin|Human|

### Miscellaneous

|Mechanism|Medication|Indications|
|-|-|-|
|NF-κB inhibitors|Steroids|Immunosuppression|
|Calcineurin inhibitors|Cyclosporine|Immunosuppression|
||Tacrolimus|Immunosuppression|
|mTOR inhibitors|Sirolimus|Immunosuppression|
||Everolimus|Immunosuppression|

## Mechanisms of Action of Monoclonal Antibodies

|Mechanism|Medication|Indications|
|-|-|-|
|Gp2b/3a inhibitors|Abciximab|Antiplatelet|
|RANKL inhibitors|Denosumab|Osteoporosis|
|IgE inhibitors|Omalizumab|Asthma|
|IL-2R inhibitors|Basiliximab|Immunosuppression|
||Daclizumab|Immunosuppression|
|TNF-α inhibitors|Infliximab|Immunosuppression|
||Adalimumab|Immunosuppression|
|CD20 inhibitors|Rituximab|Immunosuppression|
|||Non-Hodgkin lymphoma|
|EGFR inhibitors|Cetuximab|Colorectal cancer|
|HER2 inhibitors|Trastuzumab|Breast cancer|
|VEGF inhibitors|Bevacizumab|Solid tumors|
||Ranibizumab|Diabetic retinopathy|
|CAM inhibitors|Natalizumab|Multiple sclerosis|
|F protein inhibitors|Palivizumab|RSV|

## Mechanisms of Action of Tyrosine Kinase Inhibitors

|Mechanism|Medication|Indications|
|-|-|-|
|ABL1 inhibitors|Imatinib|CML|
|BRAF inhibitors|Vemurafenib|Melanoma|
|C-KIT inhibitors|Imatinib|Gastrointestinal stromal tumor (GIST)|
|EGFR inhibitors|Gefitinib & Erlotinib|Non-small cell lung cancer (NSCLC)|
|VEGFR inhibitors|Sunitinib & Sorafenib|-|

## Target Therapy

![](../Figures/Target%20Therapy.png)

## Medications Causing QT Prolongation {ABCDE}

- Antiarrhythmics :: class 1A & 3
- Antibiotics :: Macrolide & Fluoroquinolone
- Antipsychotics
- Antidepressants :: TCA
- Antiemetics :: Ondansetron

## Medications Causing Agranulocytosis

|Mnemonic|Medication|
|-|-|
|Cannot|Carbamazepine|
|Make|Methimazole|
|Circulating|Clozapine|
|Granulo-|Ganciclovir|
|Cytes|Colchicine|
|Properly|Propylthiouracil|

## Medications Causing Aplastic Anemia

|Mnemonic|Medication|
|-|-|
|Cannot|Carbamazepine|
|Make|Methimazole|
|New|NSAIDs|
|Blood|Benzene|
|Cells|Chloramphenicol|
|Properly|Propylthiouracil|

## Medications Causing Megaloblastic Anemia

- Methotrexate
- Phenytoin
- Sulfa drugs
- Trimethoprim

## Medications Causing Hemolysis in G6PD Deficiency {IS-D-PAIN}

- Isoniazid
- Sulfonamide
- Dapsone
- Primaquine
- Aspirin
- Ibuprofen
- Nitrofurantoin

## Medications Causing Osteoporosis

- Corticosteroid
- Heparin

## Medications Causing Photosensitivity {FAST}

- Flucytosine
- Amiodarone
- Sulfonamide
- Tetracycline

## Medications Causing SLE-like Syndrome {HIPPIES}

- Hydralazine
- Isoniazid
- Procainamide
- Primaquine
- Isoniazid
- Etanercept
- Sulfa drugs

## Medications Causing Seizures

- Bupropion
- Enflurane
- Imipenem
- Isoniazid

## Medications Causing Parkinson-like Syndrome {RAM}

- Reserpine
- Antipsychotics
- Metoclopramide

## Medications Causing Disulfiram-like Reaction

- Griseofulvin
- Metronidazole
- Procarbazine
- Sulfonylurea

## Medications Causing Nephrotoxicity & Ototoxicity

- Aminoglycoside
- Cisplatin
- Loop diuretics
- Vancomycin

## Medications Causing Gynecomastia

|Mnemonic|Medication|
|-|-|
|Some|Spironolactone|
|Drugs|Digoxin|
|Create|Cimetidine|
|Awesome|Alcohol|
|Knockers|Ketoconazole|

## Medications Causing SIADH

|Mnemonic|Medication|
|-|-|
|Cannot|Carbamazepine|
|Concentrate|Cyclophosphamide|
|Sodium|SSRI|

## Medications Following Zero-order Elimination {APE}

- Aspirin
- Phenytoin
- Ethanol
